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PT regimens and settings. Few studies investigated effectiveness of pharmacolog-
ical interventions for improving strength and performance. No studies estimated
the incidence, prevalence, or direct or indirect cost of muscle atrophy/weakness in
TKA. CONCLUSIONS: The impact of muscle atrophy/weakness on the cost and
treatment of TKA is poorly defined; few rehabilitation strategies fully restore
strength and function. Future research may need to evaluate the contribution of
muscle atrophy/weakness to TKA disease burden and determine optimal interven-
tions for recovery of strength and function.
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OBJECTIVES: The objective of this evaluation was to analyze the economic impact
of introducing the RRP – a program that optimizes all aspects of a patient’s journey
from pre-operative assessment to discharge and beyond, which improves patient
satisfaction of patients undergoing primary hip and knee arthroplasty, in the Nor-
wegian South-Eastern Regional Health Authority (SENRHA). METHODS: An eco-
nomic model was developed using empirical data from a retrospective evaluation
of the RRP at the public-run London based Hillingdon Hospital Trust. The model
compared the two scenarios pre- and post-implementation of the RRP where the
former scenario constituted the current clinical practice of the SENRHA and the
lattermodeled the impact of the RRP on the SENRHA by assuming transferability of
the Hillingdon results, as they are reproduced in a model developed by the Berkely
Partnership in cooperation with the hospital. The model used in this analysis syn-
thesizes the evidence from Hillingdon with Norwegian cost and LOS data. The
pre-RRP number of patients and LOS at the SENRHA were retrieved from the Nor-
wegian Patients Registry. Cost components including staff, theatre, prosthetics,
drugs, bed days, pathology and diagnostics were collected from publicly available
sources. Benefits were estimated using the Norwegian DRG-based public funding
system. The SENRHA is one of four regional Norwegian health authorities serving a
population base of 2.8 million inhabitants. RESULTS: The model predicts a 58%
reduction in LOS for patients undergoing primary hip and knee arthroplasty and
estimate a volume increase of 92% for arthroplastic surgeries. Due to a reduction in
average cost per case and increased capacity, the overall change in SENRHA‘s net
position is estimated to 70 million US dollars. CONCLUSIONS: The model suggests
that implementing the Rapid Recovery Programme in the Norwegian South-East-
ern Regional Health Authority (SENRHA) is highly cost effective.
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OBJECTIVES: Lumbar spinal fusion for treatment of spinal stenosis with back pain
and spondylolisthesis has potential for perioperative morbidity, adjacent segment
degeneration, and increased costs which have led to the investigation into less-
invasive alternative treatments. Analysis of two-year results from randomized,
controlled clinical study comparing coflex interlaminar stabilization surgery with
posterolateral spinal fusion (PLF) surgery for stenosis with spondylolisthesis dem-
onstrated clinical equivalence or superiority with coflex, and showed clear superi-
ority in perioperative outcomes. The objective of this study is to determinewhether
the actual cost of coflex procedures is favorable to PLF, as a result of decreased
resource utilization. METHODS: Actual cost of care data was available for 62 pa-
tients across 3 of the 20 sites that participated in the clinical trial comparing coflex
with PLF. Actual facility costs for each case were calculated as 2011 USD, reported
as OR costs, recovery room costs, implant costs, supplies, drugs, and medical
equipment. Assumptions of cost for implants included 1) $4-8,000 per coflex de-
vice, and 2) PLF implant costs range: $7-11,000 for 1-level, and $10-14,000 for 2-level.
RESULTS: Average blood loss, hospital stay, and OR time were substantially lower
with coflex. Based on actual costs to facilities examined, a 1-level coflex procedure
saved on average $8776 peri-operatively, compared with 1-level PLF. Similarly, a
2-level coflex procedure saved $4702 comparedwith 2-level PLF. For these patients,
%ODI improvement was similar among the 4 cohorts at 2 years: 1-level coflex
(59.5%), 1-level fusion (38.0%), 2-level coflex (63.3%), 2-level fusion (64.1%).
CONCLUSIONS: On average, 1-level coflex procedures saved $8776 per case, while
2-level coflex procedures saved on average $4702 compared with fusion, while
producing similar or improved clinical outcomes at 2 years. Our data suggest the
potential for substantial cost-savings with coflex interlaminar stabilization com-
pared with fusion in the treatment of spinal stenosis and spondylolisthesis.
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OBJECTIVES: Video-Assisted Thoratic Surgical (VATS) lobectomies and wedge re-
sections result in lower morbidity and shorter length of stay (LOS) than open tho-
racotomy. The impact of robotic-assisted VATS on clinical and economic out-
comes, however, has not been examined. This study compared hospital costs and
clinical outcomes for VATS lobectomies and wedge resections with and without
robotic assistance.METHODS: Using the Premier hospital database, patients aged
18 years with a record of thoracoscopic lobectomy (ICD-9 code 32.41), thoraco-
scopic segemental resection of lung (ICD-9 code 32.30), or thoracoscopic excision of
lesion or tissue of lung (ICD-9 code 32.20) between 2009 to Q2 2011 were identified.
Procedures utilizing robotic technology were identified if one of two conditions
weremet: (1) a robotic ICD-9 procedure code accompanied the procedure of interest
or (2) “text” fields in the hospital charge master file indicated use of robot. Data
were collected on intra-operative and post-operative complications, LOS, readmis-
sion rates, and total hospital cost for the procedures. Bivariate comparisons be-
tween VATS procedures with/without robotic assistance used MannWhiteny-U to
test for differences in median costs and surgery times. RESULTS: Of 15,502 patient
records analyzed, 96% (n14,837) were performed without robotic assistance. Us-
ing robotic assistancewas associatedwith highermedian per patient hospital costs
(not including robotic capital or service contract). Median cost of inpatient proce-
dures with/without robotic assistance was $22,331 versus $17,667 (p0.0001) for
lobectomies and $17,369 versus 13,574 (p0.0001) for wedge resections respec-
tively. Median inpatient surgery times were not significantly different for lobec-
tomy (4.03 versus 4.00) but where longer for wedge resection. Surgery hours for
robotic wedge resection versus non-robotic were 2.92 versus 2.25 (p0.0001), re-
spectively. Median LOS was similar across both groups. CONCLUSIONS: Based on
this analysis, robotic-assisted VATS for lobectomy and wedge resection appears to
have higher hospital costs and wedge resections have longer surgery times.
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OBJECTIVES: To compare clinical and economic outcomes for conventional lapa-
roscopic (LAP) and robotic assisted minimally invasive surgery for segmental
colectomies.METHODS: Using the Premier hospital database patients 18 years
of age having one of the following primary LAP colectomies performed in 2009 toQ2
2011 were identified: cecectomy, hemi colectomy, left hemi colectomy, and sig-
moidectomy. Those procedures utilizing robotic technology were identified if one
of two conditions were met: 1) A robotic ICD-9 procedure code accompanied the
primary procedure of interest, or 2) “text” fields in the hospital charge master file
indicated use of the robot. Patients were matched on laparoscopic versus robotic
colectomy using a propensity score on severity, certain demographic and hospital
characteristics, and 1:1 on type of procedure. The association between robot-as-
sisted colectomy and adverse events, hospital costs, surgery time, and length of
stay was examined. RESULTS: Of 25,758 patient records from 364 hospitals, 98%
(n25,210) of laparoscopic colectomieswere performedwithout robotic assistance;
2% (548) with robotic assistance. After matching, 1,066 patients remained, 533 in
each group. No significant differences existed between the matched cohorts for
major, minor and/or surgical complications. Use of the robot was associated with
statistically higher mean per patient hospital costs. Inpatient procedures with and
without robot assistance cost $17,445 vs. $15,447 (p0.0008) respectively. The anal-
ysis did not include capital costs or service fees associated with maintaining the
robot. Inpatient surgery times were significantly longer for robot-assisted proce-
dures thannon-robot procedures (4.37 vs. 3.34 hours; p0.0001). Length of staywas
similar. CONCLUSIONS: Findings reveal minimal clinical differences in peri and
post-operative events and length of stay. There were significant increases in cost
per case and OR time for robotic assisted versus conventional LAP procedures.
These results call into question the cost-effectiveness of this technology in these
procedures.
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OBJECTIVES: Perioperative red cell salvage (CS) – the process of collecting shed
blood during surgery and returning it to patients - reduces the need for allogeneic
blood transfusion, which results in fewer transfusion-related adverse events and
consequently more quality-adjusted life years compared to surgery without CS.
However, little is known about the cost of CS in pediatric surgery. Our objectivewas
to compare the societal costs associated with four transfusion strategies among
patients undergoing elective orthopedic or cardiac surgery in Children’s Hospital
Boston: 1) CS followed by autologous transfusion; 2) CS followed by allogeneic
transfusion; 3) autologous transfusion alone; and 4) allogeneic transfusion alone.
METHODS: A TreeAge © decision tree was used to conduct all comparisons (2010
dollars), threshold analyses, univariate and multivariate probabilistic sensitivity
analyses. The CS-related and blood processing direct, indirect and labor costs/
patientwere obtained from the hospital accounting records and the cost of a unit of
red blood cells (RBC), from nationally representative reports. Probabilities of blood
transfusion after CS and the number of RBC units returned via CS were obtained
from hospital utilization records. The probabilities and lifetime costs of a range of
infections and reactions caused by allogeneic transfusion were derived from pub-
lished sources. RESULTS: Average CS, blood processing and RBC unit costs were
$160, $1895 and $223, respectively. Average volume of blood returned via CS was
271cc, and the probability of needing transfusion after CS was 0.80. Cell salvage
with autologous blood transfusion ($1504) was least expensive, followed by CSwith
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